Clinicopathologic characteristics of NSCLC patients with uncommon EGFR mutations in Korea

被引：0
|
作者：
Kang, Hye Seon [1 ]
Kim, Kyu Yeon [2 ]
Lim, Jeong Uk [3 ]
Yeo, Chang Dong [4 ]
Kim, Ju Sang [5 ]
Kim, Seung Joon [6 ]
Lee, Sang Haak [4 ]
机构：
[1] Catholic Univ Korea, Bucheon St Marys Hosp, Resp & Crit Care Med, Bucheon, South Korea
[2] Catholic Univ Korea, Uijeongbu St Marys Hosp, Resp & Crit Care Med, Uijongbu, South Korea
[3] Catholic Univ Korea, Yeoiudo St Marys Hosp, Resp & Crit Care Med, Seoul, South Korea
[4] Catholic Univ Korea, Eunpyeong St Marys Hosp, Resp Sleep & Crit Care Med, Seoul, South Korea
[5] Catholic Univ Korea, Incheon St Marys Hosp, Resp & Crit Care Med, Incheon, South Korea
[6] Catholic Univ Korea, Seoul St Marys Hosp, Resp & Crit Care Med, Seoul, South Korea
来源：
RESPIROLOGY | 2023年 / 28卷
关键词：
D O I：
暂无
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
AO17-5
引用
收藏
页码：100 / 100
页数：1
相关论文
共 50 条
  • [21] Unveiling the Landscape of Uncommon EGFR Mutations in NSCLC-A Systematic Review
    Borgeaud, Maxime
    Parikh, Kaushal
    Banna, Giuseppe Luigi
    Kim, Floryane
    Olivier, Timothee
    Le, Xiuning
    Addeo, Alfredo
    JOURNAL OF THORACIC ONCOLOGY, 2024, 19 (07) : 973 - 983
  • [22] Hitting the Right Spot: Advances in the Treatment of NSCLC With Uncommon EGFR Mutations
    Sabari, Joshua K.
    Heymach, John V.
    Sandy, Beth
    JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2021, 19 : S1 - S11
  • [23] NSCLC with uncommon EGFR mutations treated with atezolizumab plus bevacizumab and chemotherapy
    Trummer, Arne
    Bethge, Andre
    Dickgreber, Nicolas
    Dittrich, Ina
    Golpon, Heiko
    Hoffknecht, Petra
    Overbeck, Tobias R.
    Wesseler, Claas
    Reck, Martin
    LUNG CANCER, 2022, 174 : 141 - 145
  • [24] Efficacy of first-generation EGFR-TKIs on patients with NSCLC harboring EGFR uncommon mutations: a pooled analysis
    Zhang, Y.
    Tang, S.
    Zhang, J.
    He, Q.
    He, J.
    Liang, W.
    ANNALS OF ONCOLOGY, 2016, 27
  • [25] Clinical outcomes of gefitinib and erlotinib in patients with NSCLC harboring uncommon EGFR mutations: A pooled analysis of 438 patients
    Wang, Chunsheng
    Zhao, Kewei
    Hu, Shanliang
    Dong, Wei
    Gong, Yan
    Li, Minghuan
    Xie, Conghua
    LUNG CANCER, 2022, 172 : 86 - 93
  • [26] Activity of afatinib in patients with NSCLC harboring novel uncommon EGFR mutations with or without co-mutations: a case report
    Christopoulos, Petros
    Herster, Franziska
    Hoffknecht, Petra
    Falk, Markus
    Tiemann, Markus
    Kopp, Hans-Georg
    Althoff, Andre
    Stammberger, Anja
    Laack, Eckart
    FRONTIERS IN ONCOLOGY, 2024, 14
  • [27] Investigating the Pathogenicity of Uncommon KRAS Mutations and Their Association with Clinicopathologic Characteristics in Patients with Colorectal Cancer
    Adorisio, Riccardo
    Ciardiello, Davide
    Rappa, Alessandra
    Gervaso, Lorenzo
    Pelizzari, Gloria
    Marinucci, Laura
    Fusco, Nicola
    Zampino, Maria Giulia
    Fazio, Nicola
    Venetis, Konstantinos
    Guerini-Rocco, Elena
    JOURNAL OF MOLECULAR DIAGNOSTICS, 2025, 27 (02): : 130 - 138
  • [28] Safety and Efficacy of Aumolertinib in Patients with advanced NSCLC Harboring Uncommon EGFR Mutations: Cohort 2 Updated
    Fang, W. F.
    Bu, Q.
    Wang, Q. M.
    Zhao, W. H.
    Wang, L. P.
    Dong, X. R.
    Chen, P. F.
    Wen, Z. B.
    Jia, J.
    Jiang, G. M.
    Zhang, L.
    JOURNAL OF THORACIC ONCOLOGY, 2023, 18 (11) : S333 - S334
  • [29] Molecular characteristics of EGFR exon20 mutations in NSCLC patients.
    Ji, Yinghua
    Wang, Jin
    Meng, Xiangli
    Xie, Jinling
    Lu, Ping
    Li, Mengmeng
    Luo, Ningning
    Qi, Yingxue
    Zhu, Xiaofeng
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [30] Clinicopathological Characteristics of 11 NSCLC Patients with EGFR-Exon 20 Mutations
    Lund-Iversen, Marius
    Kleinberg, Lilach
    Fjellbirkeland, Lars
    Helland, Aslaug
    Brustugun, Odd Terje
    JOURNAL OF THORACIC ONCOLOGY, 2012, 7 (09) : 1471 - 1473
12345